3.8 • 950 Ratings
🗓️ 12 December 2025
⏱️ 4 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Seeking Alpha's Wall Street Breakfast, where we cover the top news for investors |
| 0:09.2 | every morning. |
| 0:10.4 | Good morning. |
| 0:11.4 | Today is Friday, December 12th, and I'm your host, Kim Kahn, filling in for Julie Morgan. |
| 0:15.5 | The AI trade hit another speed bump, with Broadcom under pressure post-earnings on margin |
| 0:19.9 | concerns. Deutsche Bank's Jim Reid noted that after a 78% year-to-date rally with Broadcom under pressure post-earnings on margin concerns. |
| 0:26.1 | Deutsche Bank's Jim Reed noted that after a 78% year-to-date rally, Broadcom now has a larger market cap than Meta and Tesla, underscoring its central role in the AI narrative. |
| 0:31.2 | The company beat expectations in Q4 on the strength of continued AI spending, lifting |
| 0:35.6 | shares and extended trading on Thursday, until |
| 0:38.2 | CFO Kristen Spears flagged near-term margin pressure on the call. She said Q1 gross margin is |
| 0:43.9 | expected to fall about 100 basis points sequentially, largely because AI revenue is taking |
| 0:49.1 | a bigger share of the mix. Margins through 2026 will also depend on the balance between |
| 0:53.6 | infrastructure software, |
| 0:55.2 | semiconductors, and specific product lines. CEO Hawk Tan added that Broadcom has a $73 billion |
| 1:01.1 | backlog of AI product orders scheduled over the next six quarters. But that backlog includes |
| 1:06.4 | lower margin system sales, which will become a larger portion of revenue in the second half of |
| 1:10.8 | fiscal 2026. Lead time for new orders currently range from six months. margin system sales, which will become a larger portion of revenue in the second half of fiscal |
| 1:11.0 | 2026. Lead time for new orders currently range from six months to a year, depending on the product. |
| 1:17.7 | Cannabis producer stocks are jumping on reports that President Donald Trump is expected to push |
| 1:22.4 | for reclassifying marijuana as a less dangerous drug. Tilray brands, canopy growth, Aurora Cannabis, Sundial |
| 1:29.2 | and Kronos Group are among the top movers. Trump is reportedly considering shifting |
| 1:33.5 | cannabis from Schedule 1, the category for substances with no accepted medical use, to Schedule 3, |
... |
Transcript will be available on the free plan in 25 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Seeking Alpha, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Seeking Alpha and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.